Antibodies that bind complex glycosaminoglycans accumulate in the Golgi

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 29, 2013, Pages 11958-11963

  Radic, Marko ^a   Weigert, Martin G ^b   Khan, Salar N ^a   Han, Jiong ^b   Kalinina, Olga ^b   Prak, Eline T Luning ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; GLYCOSAMINOGLYCAN; IMMUNOGLOBULIN M; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; DNA BINDING; GOLGI COMPLEX; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; X RAY DIFFRACTION;

AMINO ACID SEQUENCE; B-LYMPHOCYTES; BASE SEQUENCE; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOSAMINOGLYCANS; GOLGI APPARATUS; HUMANS; HYBRIDOMAS; IMMUNOASSAY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN VARIABLE REGION; LUMINESCENT MEASUREMENTS; MICROSCOPY, CONFOCAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; X-RAY DIFFRACTION;

EID: 84880373190     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1308620110     Document Type: Article

References (44)

1. Nemazee D (2006) Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol 6(10):728-740.
2. Fournier EM, et al. (2012) Dual-reactive B cells are autoreactive and highly enriched in the plasmablast and memory B cell subsets of autoimmune mice. J Exp Med 209(10): 1797-1812.
3. Li Y, Li H, Weigert M (2002) Autoreactive B cells in the marginal zone that express dual receptors. J Exp Med 195(2):181-188.
4. Casellas R, et al. (2007) Igkappa allelic inclusion is a consequence of receptor editing. J Exp Med 204(1):153-160.
5. Liu S, et al. (2005) Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens. J Immunol 175(8): 5067-5076.
6. Huang H, Kearney JF, Grusby MJ, Benoist C, Mathis D (2006) Induction of tolerance in arthritogenic B cells with receptors of differing affinity for self-Antigen. Proc Natl Acad Sci USA 103(10):3734-3739.
7. Gay D, Saunders T, Camper S, Weigert M (1993) Receptor editing: An approach by autoreactive B cells to escape tolerance. J Exp Med 177(4):999-1008.
8. Li H, et al. (2003) Regulation of anti-phosphatidylserine antibodies. Immunity 18(2): 185-192.
9. Witsch EJ, Cao H, Fukuyama H, Weigert M (2006) Light chain editing generates polyreactive antibodies in chronic graft-versus-host reaction. J Exp Med 203(7):1761-1772.
10. Chen X, Martin F, Forbush KA, Perlmutter RM, Kearney JF (1997) Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int Immunol 9(1):27-41.
11. Khan SN, et al. (2008) Editing and escape from editing in anti-DNA B cells. Proc Natl Acad Sci USA 105(10):3861-3866.
12. Radic MZ, et al. (1993) Residues that mediate DNA binding of autoimmune antibodies. J Immunol 150(11):4966-4977.
13. Radic MZ, Weigert M (1994) Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol 12:487-520.
14. Radic MZ, Erikson J, Litwin S, Weigert M (1993) B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med 177(4):1165-1173.
15. Ibrahim SM, Weigert M, Basu C, Erikson J, Radic MZ (1995) Light chain contribution to specificity in anti-DNA antibodies. J Immunol 155(6):3223-3233.
16. Li H, Jiang Y, Prak EL, Radic M, Weigert M (2001) Editors and editing of anti-DNA receptors. Immunity 15(6):947-957.
17. Li P, et al. (2007) The structure of a polyQ-Anti-polyQ complex reveals binding according to a linear lattice model. Nat Struct Mol Biol 14(5):381-387.
18. Chen C, et al. (1994) Deletion and editing of B cells that express antibodies to DNA. J Immunol 152(4):1970-1982.
19. Galin FS, Maier CC, Zhou SR, Whitaker JN, Blalock JE (1996) Murine V lambda x and V lambda x-containing antibodies bind human myelin basic protein. J Clin Invest 97(2): 486-492.
20. Shlomchik MJ, Aucoin AH, Pisetsky DS, Weigert MG (1987) Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc Natl Acad Sci USA 84(24):9150-9154.
21. Cocca BA, et al. (2001) Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells. Proc Natl Acad Sci USA 98(24): 13826-13831.
22. Boudinot P, Drapier AM, Cazenave PA, Sanchez P (1994) Mechanistic and selective constraints act on the establishment of V lambda J lambda junctions in the B cell repertoire. J Immunol 152(5):2248-2255.
23. Doyle CM, Han J, Weigert MG, Prak ET (2006) Consequences of receptor editing at the lambda locus: Multireactivity and light chain secretion. Proc Natl Acad Sci USA 103(30):11264-11269.
24. Khan SN, et al. (2011) Intra-Golgi formation of IgM-glycosaminoglycan complexes promotes Ig deposition. J Immunol 187(6):3198-3207.
25. Linstedt AD, Hauri HP (1993) Giantin, a novel conserved Golgi membrane protein containing a cytoplasmic domain of at least 350 kDa. Mol Biol Cell 4(7):679-693.
26. Nozawa K, Fritzler MJ, von Mühlen CA, Chan EK (2004) Giantin is the major Golgi autoantigen in human anti-Golgi complex sera. Arthritis Res Ther 6(2):R95-R102.
27. Ko J, Ou S, Patterson PH (2001) New anti-huntingtin monoclonal antibodies: Implications for huntingtin conformation and its binding proteins. Brain Res Bull 56(3-4): 319-329.
28. Lee JE, et al. (2008) Complex of a protective antibody with its Ebola virus GP peptide epitope: Unusual features of a V lambda x light chain. J Mol Biol 375(1):202-216.
29. McKinstry WJ, et al. (2009) Structural basis for antibody discrimination between two hormones that recognize the parathyroid hormone receptor. J Biol Chem 284(23): 15557-15563.
30. Liu Y, et al. (2007) Lupus susceptibility genes may breach tolerance to DNA by impairing receptor editing of nuclear antigen-reactive B cells. J Immunol 179(2):1340-1352.
31. Bankovich AJ, et al. (2007) Structural insight into pre-B cell receptor function. Science 316(5822):291-294.
32. Keenan RA, et al. (2008) Censoring of autoreactive B cell development by the pre-B cell receptor. Science 321(5889):696-699.
33. Sörme P, et al. (2005) Structural and thermodynamic studies on cation-Pi interactions in lectin-ligand complexes: High-Affinity galectin-3 inhibitors through fine-tuning of an arginine-Arene interaction. J Am Chem Soc 127(6):1737-1743.
34. Peters O, et al. (1984) Intracellular inclusion bodies in 14 patients with B cell lymphoproliferative disorders. J Clin Pathol 37(1):45-50.
35. Kishi Y, et al. (2012) Apoptotic marginal zone deletion of anti-Sm/ribonucleoprotein B cells. Proc Natl Acad Sci USA 109(20):7811-7816.
36. Sanchez P, Cazenave PA (1987) A new variable region in mouse immunoglobulin lambda light chains. J Exp Med 166(1):265-270.
37. Kawasaki K, et al. (1997) One-megabase sequence analysis of the human immunoglobulin lambda gene locus. Genome Res 7(3):250-261.
38. Sanchez P, Marche PN, Rueff-Juy D, Cazenave PA (1990) Mouse V lambda x gene sequence generates no junctional diversity and is conserved in mammalian species. J Immunol 144(7):2816-2820.
39. Wilson JA, et al. (2000) Epitopes involved in antibody-mediated protection from Ebola virus. Science 287(5458):1664-1666.
40. Mouquet H, et al. (2012) Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. Proc Natl Acad Sci USA 109(47):E3268-E3277.
41. Cohn M, Langman RE (1990) The protection: The unit of humoral immunity selected by evolution. Immunol Rev 115:11-147.
42. Blomberg B, Geckeler WR, Weigert M (1972) Genetics of the antibody response to dextran in mice. Science 177(4044):178-180.
43. Clarke SH, et al. (1985) Inter-And intraclonal diversity in the antibody response to influenza hemagglutinin. J Exp Med 161(4):687-704.
44. Amrani YM, Voegtlé D, Barbier E, Six A, Cazenave PA (2004) Marginal zone B cell enrichment and strong follicular B cell reduction correlate with a delayed IgG response in a light chain diversity restricted mouse model. Eur J Immunol 34(10): 2812-2823.